Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Topical dorzolamide therapy for taxane-related macular oedema.

× No keyword cloud information.

5 in total

1. Cystoid macular edema secondary to albumin-bound paclitaxel therapy.

Authors: Stacy V Smith; Matthew S Benz; David M Brown
Journal: Arch Ophthalmol Date: 2008-11

2. Abraxane-induced cystoid macular edema refractory to concomitant intravenous bevacizumab.

Authors: Darrell E Baskin; Sunir J Garg
Journal: Can J Ophthalmol Date: 2011-04 Impact factor: 1.882

3. Regression of paclitaxel-induced maculopathy with oral acetazolamide.

Authors: Kerstin Maria Meyer; Thomas Klink; Selma Ugurel; Eva-Bettina Bröcker
Journal: Graefes Arch Clin Exp Ophthalmol Date: 2011-03-23 Impact factor: 3.117

4. Continued use of dorzolamide for the treatment of cystoid macular oedema in patients with retinitis pigmentosa.

Authors: Gerald A Fishman; Marsha A Apushkin
Journal: Br J Ophthalmol Date: 2007-01-10 Impact factor: 4.638

5. Efficacy of sustained topical dorzolamide therapy for cystic macular lesions in patients with X-linked retinoschisis.

Authors: Mohamed A Genead; Gerald A Fishman; Saloni Walia
Journal: Arch Ophthalmol Date: 2010-02

5 in total

10 in total

1. Macular retinal detachment associated with intrachoroidal cavitation in myopic patients.

Authors: Ta-Ching Chen; Chang-Hao Yang; Jen-Pin Sun; Muh-Shy Chen; Chung-May Yang
Journal: Graefes Arch Clin Exp Ophthalmol Date: 2014-11-04 Impact factor: 3.117

2. Cystoid macular edema associated with chemotherapy.

Authors: Rajesh C Rao; Netan Choudhry
Journal: CMAJ Date: 2015-08-04 Impact factor: 8.262

3. EFFECT OF INTRAOCULAR PRESSURE-LOWERING MEDICATIONS ON NEOVASCULAR AGE-RELATED MACULAR DEGENERATION TREATMENT OUTCOMES IN THE COMPARISON OF AGE-RELATED MACULAR DEGENERATION TREATMENT TRIALS.

Authors: Ehsan Rahimy; Gui-Shuang Ying; Wei Pan; Jason Hsu
Journal: Retina Date: 2019-04 Impact factor: 4.256

Review 4. Cystoid macular oedema without leakage in fluorescein angiography: a literature review.

Authors: Masood Naseripour; Sara Hemmati; Samira Chaibakhsh; Arzhang Gordiz; Leila Miri; Fatemeh Abdi
Journal: Eye (Lond) Date: 2022-09-10 Impact factor: 4.456

5. Single-eye trial of a topical carbonic anhydrase inhibitor versus intravitreal bevacizumab for the treatment of taxane drug-induced cystoid macula oedema.

Authors: Mark M Hassall; Nicholas Howard Andrew
Journal: BMJ Case Rep Date: 2016-04-19

Review 6. Emerging therapies in the management of macular edema: a review.

Authors: Riccardo Sacconi; Chiara Giuffrè; Eleonora Corbelli; Enrico Borrelli; Giuseppe Querques; Francesco Bandello
Journal: F1000Res Date: 2019-08-12

7. Intravitreal Ranibizumab Had Limited Effect on Cystoid Macular Edema Due to Albumin-Bound Paclitaxel: A Case Report and Literature Review.

Authors: Suna Ye; Qiqi Fang; Jinyu Yao; Jianqiang Xing; Shibo Tang; Jacey Hongjie Ma
Journal: Front Oncol Date: 2021-12-13 Impact factor: 6.244

8. Sub-Tenon Injections of Triamcinolone Acetonide Had Limited Effect on Cystoid Macular Edema Secondary to Nanoparticle Albumin-Bound-Paclitaxel (Abraxane).

Authors: Naoki Matsuoka; Hiruma Hasebe; Tetsuji Mayama; Takeo Fukuchi
Journal: Case Rep Ophthalmol Med Date: 2015-08-23

9. Dexamethasone intravitreal implant in cystoid macular edema secondary to paclitaxel therapy.

Authors: Barbara Burgos-Blasco; Samuel Hernandez-Ruiz; Lorenzo Lopez-Guajardo; Juan Donate-Lopez
Journal: Am J Ophthalmol Case Rep Date: 2020-03-07

10. Regression of taxane-related cystoid macular edema after topical dorzolamide treatment: two case reports.

Authors: Mitsuru Otsubo; Reiko Kinouchi; Takayuki Kamiya; Akitoshi Yoshida
Journal: J Med Case Rep Date: 2021-07-21

10 in total